Skip to main content
. 2018 Dec 19;2018(12):CD012346. doi: 10.1002/14651858.CD012346.pub2

Comparison 2. Selective serotonin reuptake inhibitor versus placebo ‐ final follow‐up values used.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Change in depressive symptoms 2 148 Std. Mean Difference (IV, Random, 95% CI) 0.75 [‐1.14, 2.64]
2 Adverse events 3   Odds Ratio (M‐H, Random, 95% CI) Subtotals only
2.1 Nausea 3 171 Odds Ratio (M‐H, Random, 95% CI) 2.32 [0.66, 8.12]
2.2 Dizziness 2 143 Odds Ratio (M‐H, Random, 95% CI) 0.61 [0.09, 4.06]
3 Change in FEV1 2 148 Mean Difference (IV, Random, 95% CI) 0.01 [‐0.03, 0.05]
4 Change in quality of life 2 148 Std. Mean Difference (IV, Random, 95% CI) 1.17 [‐0.80, 3.15]
5 Change in exercise tolerance 2 148 Mean Difference (IV, Random, 95% CI) 13.88 [11.73, 16.03]